BSE Live
Jan 23, 16:01Prev. Close
458.10
Open Price
458.20
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Jan 23, 15:48Prev. Close
458.00
Open Price
460.75
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
440.25 (137)
| Key Financial Ratios of Thyrocare Technologies (in Rs. Cr.) | Mar 20 | Mar 19 | Mar 18 | Mar 17 | Mar 16 | |
| Per Share Ratios | ||||||
| Basic EPS (Rs.) | 16.74 | 15.95 | 17.39 | 7.99 | 10.06 | |
| Diluted EPS (Rs.) | 16.71 | 15.91 | 17.34 | 8.13 | 10.06 | |
| Cash EPS (Rs.) | 22.67 | 20.96 | 21.10 | 11.34 | 13.04 | |
| Book Value [ExclRevalReserve]/Share (Rs.) | 69.39 | 82.42 | 82.51 | 75.96 | 68.05 | |
| Book Value [InclRevalReserve]/Share (Rs.) | 69.39 | 82.42 | 82.51 | 75.96 | 68.05 | |
| Revenue from Operations/Share (Rs.) | 82.18 | 76.32 | 66.32 | 56.69 | 44.85 | |
| PBDIT/Share (Rs.) | 34.11 | 31.10 | 31.22 | 23.73 | 18.62 | |
| PBIT/Share (Rs.) | 28.07 | 26.14 | 27.48 | 20.37 | 15.23 | |
| PBT/Share (Rs.) | 26.48 | 26.03 | 26.99 | 15.21 | 15.23 | |
| Net Profit/Share (Rs.) | 16.63 | 16.00 | 17.36 | 7.98 | 9.64 | |
| NP After MI And SOA / Share (Rs.) | 16.73 | 16.13 | 17.36 | 7.98 | 9.64 | |
| Profitability Ratios | ||||||
| PBDIT Margin (%) | 41.50 | 40.74 | 47.07 | 41.86 | 41.51 | |
| PBIT Margin (%) | 34.15 | 34.25 | 41.43 | 35.93 | 33.94 | |
| PBT Margin (%) | 32.21 | 34.10 | 40.69 | 26.83 | 33.94 | |
| Net Profit Margin (%) | 20.23 | 20.96 | 26.17 | 14.07 | 21.49 | |
| NP After MI And SOA Margin (%) | 20.35 | 21.13 | 26.17 | 14.07 | 21.49 | |
| Return on Networth/Equity (%) | 24.11 | 19.56 | 21.04 | 10.50 | 14.16 | |
| Return on Capital Employed (%) | 38.11 | 30.38 | 32.18 | 26.02 | 21.62 | |
| Return on Assets (%) | 18.77 | 17.93 | 19.47 | 9.78 | 12.64 | |
| Total Debt/Equity (X) | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 | |
| Asset Turnover Ratio (%) | 92.22 | 84.87 | 74.38 | 69.52 | 58.81 | |
| Liquidity Ratios | ||||||
| Current Ratio (X) | 1.86 | 6.61 | 7.02 | 8.49 | 4.28 | |
| Quick Ratio (X) | 1.61 | 5.73 | 6.18 | 7.66 | 3.94 | |
| Inventory Turnover Ratio (X) | 21.06 | 22.28 | 20.90 | 21.00 | 22.48 | |
| Dividend Payout Ratio (NP) (%) | 149.32 | 31.54 | 57.59 | 94.04 | 99.10 | |
| Dividend Payout Ratio (CP) (%) | 109.71 | 24.13 | 47.38 | 66.16 | 73.29 | |
| Earnings Retention Ratio (%) | -49.32 | 68.46 | 42.41 | 5.96 | 0.90 | |
| Cash Earnings Retention Ratio (%) | -9.71 | 75.87 | 52.62 | 33.84 | 26.71 | |
| Coverage Ratios | ||||||
| Interest Coverage Ratios (%) | 80.18 | 226.25 | 339.36 | 408.12 | -- | |
| Interest Coverage Ratios (Post Tax) (%) | 80.18 | 226.25 | 339.36 | 408.12 | -- | |
| Valuation Ratios | ||||||
| Enterprise Value (Cr.) | 2,609.92 | 2,793.41 | 3,217.70 | 3,830.80 | 0.00 | |
| EV/Net Operating Revenue (X) | 6.01 | 6.93 | 9.03 | 12.59 | 0.00 | |
| EV/EBITDA (X) | 14.48 | 17.01 | 19.18 | 30.06 | 0.00 | |
| MarketCap/Net Operating Revenue (X) | 6.03 | 6.95 | 9.06 | 12.62 | 0.00 | |
| Retention Ratios (%) | -49.32 | 68.45 | 42.40 | 5.95 | 0.89 | |
| Price/BV (X) | 7.14 | 6.44 | 7.29 | 9.42 | 0.00 | |
| Price/Net Operating Revenue | 6.03 | 6.95 | 9.06 | 12.62 | 0.00 | |
| Earnings Yield | 0.03 | 0.03 | 0.03 | 0.01 | 0.00 |
28.10.2025
Thyrocare Techn Consolidated September 2025 Net Sales at Rs 216.53 crore, up 22.09% Y-o-Y
24.10.2025
15.10.2025
Thyrocare Techn Consolidated September 2025 Net Sales at Rs 216.53 crore, up 22.09% Y-o-Y
15.10.2025
Thyrocare Techn Standalone September 2025 Net Sales at Rs 202.23 crore, up 24.03% Y-o-Y
28.10.2025
Thyrocare Techn Consolidated September 2025 Net Sales at Rs 216.53 crore, up 22.09% Y-o-Y
15.10.2025
Thyrocare Techn Consolidated September 2025 Net Sales at Rs 216.53 crore, up 22.09% Y-o-Y
15.10.2025
Thyrocare Techn Standalone September 2025 Net Sales at Rs 202.23 crore, up 24.03% Y-o-Y
24.07.2025
Thyrocare Techn Standalone June 2025 Net Sales at Rs 178.89 crore, up 24.55% Y-o-Y
06.10.2021
Thyrocare Technologies Q2 PAT may dip 2.9% YoY to Rs 41.8 cr: Prabhudas Lilladher
12.07.2019
Thyrocare Technologies Q1 PAT may dip 6.5% YoY to Rs. 22.1 cr: Prabhudas Lilladher
12.04.2019
Thyrocare Technologies Q4 PAT seen up 18.1% YoY to Rs. 29.7 cr: Prabhudas Lilladher
17.04.2018
Thyrocare Technologies Q4 PAT seen up 68.7% YoY to Rs 32 cr: Edelweiss